Beacon Therapeutics

Beacon Therapeutics

MA - Cambridge
Biotechnology1 H-1B visas (FY2023)
WebsiteLinkedInCareers Page

Focus: Gene Therapy

Beacon Therapeutics is a life sciences company focused on Gene Therapy.

Gene Therapy
Funding Stage
PUBLIC
Open Jobs
0

Pipeline & Clinical Trials

Phone-Based Health Coaching Utilizing Lifestyle Action Plans
Type2 Diabetes
N/A
Clinical Trials (1)
NCT04872647Pilot of Virtual Health Coaching Utilizing Lifestyle for Under-Resourced Patients With Type II Diabetes
N/A
N/A
Clinical Trials (1)
NCT06432920A Wearable In-phase Chest Wall Vibration Device for Relief of Dyspnoea in COPD: a First-in-human Exploratory Study
N/A
Clinical and Genetic Characterization of Individuals With Achromatopsia
Achromatopsia
N/A
Clinical Trials (1)
NCT01846052Clinical and Genetic Characterization of Individuals With Achromatopsia
N/A
Clinical Evaluation of Patients With X-linked Retinitis Pigmentosa (XLRP)
X-Linked Retinitis Pigmentosa
N/A
Clinical Trials (1)
NCT03314207Clinical Evaluation of Patients With X-linked Retinitis Pigmentosa (XLRP)
N/A
PulseAI ECG Platform
Arrhythmias, Cardiac
N/A
Clinical Trials (1)
NCT05668377Automated Diagnostic Performance of Smartwatch ECG for Arrhythmia Detection Using the PulseAI Neural Network.
N/A
Intensive Interaction with Music
Child Development Disorders, Specific
N/A
Clinical Trials (1)
NCT03188016Improvised Music to Enhance Intensive Interaction Version 1
N/A
Bismuth-based quadruple therapy
Gastric Cancer
N/A
Clinical Trials (1)
NCT06275204H. Pylori Screen-and-treat Study in a Population of Young Adults
N/A
Dorzolamide 2% TID or brinzolamide 1% TID
X-linked Retinoschisis
N/A
Clinical Trials (1)
NCT02331173Clinical Evaluation of Patients With X-linked Retinoschisis
N/A
Dreem 3S recording
Narcolepsy Type 1
N/A
Clinical Trials (1)
NCT06531876Efficacy of the Dreem 3S Ambulatory Sleep Monitoring Device for the Evaluation of Narcolepsy
N/A
palliative radiotherapy
Metastatic Tumors
N/A
Clinical Trials (1)
NCT03862911Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic (1-3 Metastases) Cancer
N/A
Assessment and Prediction of Cardiovascular Health and Disease Risk Using Wearable Biometrics.
Cardiovascular Diseases (CVD)
N/A
Clinical Trials (1)
NCT07401550Assessment and Prediction of Cardiovascular Health and Disease Risk Using Wearable Biometrics.
N/A
N/A
Clinical Trials (1)
NCT02830750Low Fluoroscopy Afib Ablation Registry
N/A
Nighttime Deep Brain Stimulation with Varying Amplitude Settings
Parkinson Disease
N/A
Clinical Trials (1)
NCT07110376Deep Brain Stimulation Neural Recordings of Varied Stimulation During Sleep in Parkinson's Disease
N/A
N/A
Clinical Trials (1)
NCT05882266The Role of Plant-Based Omega-3 Fatty Acids and Molecular Characterisation in Individuals with Cardiovascular(CVD) Risk
N/A
Phase 1
Clinical Trials (1)
NCT00430768Experimental Gene Transfer Procedure to Treat Alpha 1-Antitrypsin (AAT) Deficiency
Phase 1
rAAV2tYF-PR1.7-hCNGB3
Achromatopsia
Phase 1/2
Clinical Trials (1)
NCT02599922Safety and Efficacy Trial of AAV Gene Therapy in Patients With CNGB3 Achromatopsia (A Clarity Clinical Trial)
Phase 1/2
rAAV2tYF-CB-hRS1
X-linked Retinoschisis
Phase 1/2
Clinical Trials (1)
NCT02416622Safety and Efficacy of rAAV-hRS1 in Patients With X-linked Retinoschisis (XLRS)
Phase 1/2
Phase 1/2
Clinical Trials (1)
NCT02935517Safety and Efficacy Trial of AAV Gene Therapy in Patients With CNGA3 Achromatopsia (A Clarity Clinical Trial)
Phase 1/2
Phase 1/2
Clinical Trials (1)
NCT00749957Phase 1/2 Safety and Efficacy Study of AAV-RPE65 Vector to Treat Leber Congenital Amaurosis
Phase 1/2
Phase 1/2
Clinical Trials (1)
NCT03316560Safety and Efficacy of rAAV2tYF-GRK1-RPGR in Subjects With X-linked Retinitis Pigmentosa Caused by RPGR Mutations
Phase 1/2
Phase 2
Clinical Trials (1)
NCT01054339Safety & Efficacy Study of rAAV1-CB-hAAT for Alpha-1 Antitrypsin Deficiency
Phase 2
telephone depression care management
Depression
Phase 2
Phase 2
Clinical Trials (1)
NCT06275620A Study Comparing Two Doses of AGTC-501 in Male Participants With X-linked Retinitis Pigmentosa Caused by RPGR Mutations (DAWN)
Phase 2
Phase 2
Clinical Trials (1)
NCT06333249A Study Comparing Two Doses of AGTC-501 in Male Subjects With X-linked Retinitis Pigmentosa Caused by RPGR Mutations (SKYLINE)
Phase 2
Adeno-associated virus vector expressing a human RPGR gene
X-Linked Retinitis Pigmentosa (XLRP)
Phase 2
Clinical Trials (1)
NCT07174726A Phase 2 Open-label Study to Evaluate the Safety of Laruparetigene Zovaparvovec Administered Bilaterally in Male Participants With X-Linked Retinitis Pigmentosa
Phase 2
rAAV2tYF-GRK1-hRPGRco
X-Linked Retinitis Pigmentosa
Phase 2/3
Clinical Trials (1)
NCT04850118A Clinical Trial Evaluating the Safety and Efficacy of a Single Subretinal Injection of AGTC-501 in Participants With XLRP
Phase 2/3
Phase 2/3
Clinical Trials (1)
NCT07262723Levosimendan in Acute Decompensated Heart Failure
Phase 2/3
Phase 2/3
Clinical Trials (1)
NCT07290088Phase II/III Trial of PRL3-Zumab in Advanced Solid Tumor Patients
Phase 2/3
Perfusion CMR for detection of coronary artery disease
Coronary Artery Disease
Phase 3
Clinical Trials (1)
NCT00977093A Study of Gadodiamide Injection in Myocardial Perfusion Magnetic Resonance Imaging
Phase 3

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts
Founded: 2021
Portfolio: 28 clinical trials
H-1B (2023): 1 approval

Visa Sponsorship

Sponsors Work Visas
H-1B Petitions (FY2023)
1
Approved
0
Denied
100%
Rate

Source: USCIS H-1B Employer Data Hub